Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
Mastitis Network, Faculty of Veterinary Medicine, University of Montreal, Saint-Hyacinthe, QC, Canada.
J Antimicrob Chemother. 2021 Feb 11;76(3):561-575. doi: 10.1093/jac/dkaa443.
There is ongoing debate regarding potential associations between restrictions of antimicrobial use and prevalence of antimicrobial resistance (AMR) in bacteria.
To summarize the effects of interventions reducing antimicrobial use in food-producing animals on the prevalence of AMR genes (ARGs) in bacteria from animals and humans.
We published a full systematic review of restrictions of antimicrobials in food-producing animals and their associations with AMR in bacteria. Herein, we focus on studies reporting on the association between restricted antimicrobial use and prevalence of ARGs. We used multilevel mixed-effects models and a semi-quantitative approach based on forest plots to summarize findings from studies.
A positive effect of intervention [reduction in prevalence or number of ARGs in group(s) with restricted antimicrobial use] was reported from 29 studies for at least one ARG. We detected significant associations between a ban on avoparcin and diminished presence of the vanA gene in samples from animals and humans, whereas for the mecA gene, studies agreed on a positive effect of intervention in samples only from animals. Comparisons involving mcr-1, blaCTX-M, aadA2, vat(E), sul2, dfrA5, dfrA13, tet(E) and tet(P) indicated a reduced prevalence of genes in intervention groups. Conversely, no effects were detected for β-lactamases other than blaCTX-M and the remaining tet genes.
The available body of scientific evidence supported that restricted use of antimicrobials in food animals was associated with an either lower or equal presence of ARGs in bacteria, with effects dependent on ARG, host species and restricted drug.
关于限制抗菌药物使用与细菌对抗菌药物耐药性(AMR)流行之间的潜在关联,一直存在争议。
总结减少食用动物抗菌药物使用的干预措施对动物和人类细菌中 AMR 基因(ARGs)流行率的影响。
我们发表了一项关于限制食用动物抗菌药物及其与细菌 AMR 关联的全面系统评价。在此,我们重点关注报告限制抗菌药物使用与 ARG 流行率之间关联的研究。我们使用多水平混合效应模型和基于森林图的半定量方法来总结研究结果。
29 项研究报告了干预措施的积极效果(在限制抗菌药物使用的组中,至少有一种 ARG 的流行率或数量减少)。我们发现,在动物和人类样本中,禁止使用阿伏帕星与 vanA 基因的存在减少之间存在显著关联,而对于 mecA 基因,研究仅在动物样本中一致认为干预具有积极效果。涉及 mcr-1、blaCTX-M、aadA2、vat(E)、sul2、dfrA5、dfrA13、tet(E)和 tet(P)的比较表明,干预组中基因的流行率降低。相反,除 blaCTX-M 和其余 tet 基因外,β-内酰胺酶未检测到效果。
现有科学证据表明,限制食用动物抗菌药物的使用与细菌中 ARGs 的存在呈负相关或相当,其效果取决于 ARG、宿主物种和受限药物。